EVO
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90297845
- Registration number
- 7502626
- Mark type
- Design + words
- Filed
- 04 Nov 2020
- Published for opposition
- 25 May 2021
- Registered
- 10 Sept 2024
- Attorney of record
- Julia Spoor Gard
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical research and development; research and development of immunopharmaceuticals, vaccines, and medicines
Owner
- Evommune, Inc., Palo Alto, CA, US
- Evommune, Inc., Palo Alto, CA, US
- Evommune, Inc., Los Altos, CA, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jul 2024 — USE AMENDMENT FILED
- 22 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2024 — SOU EXTENSION 5 GRANTED
- 21 Jan 2024 — SOU EXTENSION 5 FILED
- 06 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2023 — SOU EXTENSION 4 GRANTED
- 20 Jul 2023 — SOU EXTENSION 4 FILED